Lixte Biotechnology (LIXT) Insider Trading & Ownership $1.52 +0.03 (+2.01%) (As of 11/21/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Lixte Biotechnology (NASDAQ:LIXT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.80%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$75,906.00Number OfInsiders Selling(Last 3 Years)0 Get LIXT Insider Trade Alerts Want to know when executives and insiders are buying or selling Lixte Biotechnology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LIXT Insider Buying and Selling by Quarter Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Lixte Biotechnology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails10/3/2023Der Baan Bastiaan Jeroen VanCEOBuy10,000$2.80$28,000.00 12/15/2022Rene BernardsDirectorBuy1,500$5.10$7,650.00 12/12/2022Rene BernardsDirectorBuy1,000$6.10$6,100.00 11/21/2022Eric FormanCOOBuy145$5.60$812.00 11/21/2022Regina BrownDirectorBuy500$5.80$2,900.00 11/17/2022Eric FormanCOOBuy485$5.40$2,619.00 11/14/2022Rene BernardsDirectorBuy5,250$5.30$27,825.00 (Data available from 1/1/2013 forward) LIXT Insider Trading Activity - Frequently Asked Questions Who is on Lixte Biotechnology's Insider Roster? The list of insiders at Lixte Biotechnology includes Der Baan Bastiaan Jeroen Van, Eric Forman, Regina Brown, and Rene Bernards. Learn more on insiders at LIXT. What percentage of Lixte Biotechnology stock is owned by insiders? 14.80% of Lixte Biotechnology stock is owned by insiders. Learn more on LIXT's insider holdings. Which Lixte Biotechnology insiders have been buying company stock? The following insiders have purchased LIXT shares in the last 24 months: Der Baan Bastiaan Jeroen Van ($28,000.00), Eric Forman ($812.00), Regina Brown ($2,900.00), and Rene Bernards ($13,750.00). How much insider buying is happening at Lixte Biotechnology? Insiders have purchased a total of 13,145 LIXT shares in the last 24 months for a total of $45,462.00 bought. Lixte Biotechnology Key ExecutivesMr. Bastiaan van der Baan M.Sc. (Age 52)President, CEO & Chairman of the Board of Directors Compensation: $172.78kMr. Robert Neal Weingarten (Age 72)VP & CFO Compensation: $175kMr. Eric J. Forman J.D. (Age 45)VP & COO Compensation: $200kMr. Johannes Henricus Matthias Schellens M.D. (Age 68)Ph.D., Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies AIM ImmunoTech Insider Transactions Sensei Biotherapeutics Insider Transactions Aspira Women's Health Insider Transactions NKGen Biotech Insider Transactions Talphera Insider Transactions Eagle Pharmaceuticals Insider Transactions Turnstone Biologics Insider Transactions Indaptus Therapeutics Insider Transactions Imunon Insider Transactions Mustang Bio Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:LIXT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track reco...Genesis Gold Group | Sponsored2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—wit...Darwin | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will con...DTI | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and ...WealthPress | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lixte Biotechnology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lixte Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
